Research demonstrates cobalt chelation by CbiX S in Archaeoglobus fulgidus, suggesting its role in vitamin B12 synthesis.
Archaeoglobus fulgidus CbiXS is a small (16 kDa) class II chelatase with structural homology to the CfbA nickel chelatase required for the biosynthesis of cofactor F₄₃₀. However, the biochemical function of A. fulgidus CbiXS has remained a point of confusion in the literature, with assignments as either a cobalt or a nickel chelatase. In this work, we analyze the genome of A. fulgidus revealing that the organism lacks the cofactor F₄₃₀ biosynthetic pathway but contains a nearly complete vitamin B₁₂ biosynthetic pathway, lacking a cobalt chelatase. Characterization of CbiXS using UV circular dichroism spectroscopy suggests that the protein remains folded in the pH 6-8 range. Using established competitive binding assays, it was discovered that divalent metal binding by CbiXS is a notable exception to the Irving-Williams series, with Co(II) and Ni(II) binding affinities within error of one another at pH 7.0. Additional competitive binding experiments at pH 6.0 and 8.0 suggest that Co(II) and Ni(II) are ligated by amino acids with side-chain pKa values between 6.0 and 7.0. Collectively, these data lead to the assignment of CbiXS as a novel cobalt chelatase, distinct from CbiK or CbiXL. Based upon site-directed mutagenesis, Co(II) is most likely ligated by His10 and His74.
No takes yet. Share an insight, caveat, or question.
Morris et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: